Lexaria Bioscience (LEXX) executive compensation, 2025 proxy

Richard Christopher, Chief Executive Officer, was paid $612,520 in 2025, up 18% from $519,317 the year before.

Filed
December 10, 2025
Annual meeting
January 27, 2026
Pay year
2025
Named executives
5
CEO total pay
$612,520+18% vs prior year
CEO pay in equity
19%$118,919 in awards
Prior say-on-pay support
97%of votes cast
CEO Base Salary
$420,000Effective August 31, 2024
Say-on-Pay Support
97%2025 annual meeting
CEO Stock Options
200,000Initial option issuance

How Christopher was paid

$612,520 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Named executive officers

ExecutiveTotal
Richard ChristopherChief Executive Officer$612,520
Christopher BunkaChairman, Former CEO$280,783
John DochertyPresident & CSO$523,503
Michael ShankmanChief Financial Officer$248,392
Nelson CabatuanFormer CFO$474,578

What changed and why

  • $613KRichard Christopher received a total compensation of $612,520 for fiscal 2025 as Chief Executive Officer.
  • Executive bonuses reward the successful completion of performance milestones achieved during the fiscal year.
  • 97%Shareholder advisory vote on executive compensation received 97% support in 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.